logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Istvan Kaldor

This inventor holds 19 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Cenes Limited, Vertex Pharmaceuticals, Inc., Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2001-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Istvan Kaldor. Retrieved from https://idiyas.com/inventor/istvan-kaldor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 63.2


Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 192(Granted Patents)


Location History:

  • Durham, NC (US) (2001 - 2013)
  • Research Triangle Park, NC (US) (2008 - 2021)

Company Filing History:

goldMedal5 out of 11 
 
Cenes Limited
 patents
silverMedal5 out of 1,169 
 
Vertex Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 95 
 
Glaxosmithkline Intellectual Property (No.2) Limited
 patents
4. 2 out of 358 
 
Glaxosmithkline LLC
 patents
5. 2 out of 2,198 
 
Smithkline Beecham Corporation
 patents
6. 1 out of 1,170 
 
Glaxo Group Limited
 patents
7. 1 out of 281 
 
Glaxo Wellcome Inc.
 patents

Years Active: 2001-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Crystalline Forms
Aspartyl Protease Inhibitors
Androgen Receptor Modulators
Sulphonamide Derivatives
Benzodiazepines
RXR Ligands
PPAR-gamma Agonists
Aniline Derivatives
Surfactant Compounds
Nitrobenzyl Derivatives
Methylsulfonyl Compounds
19 patents (USPTO):Explore Patents
1. 11001556 - Crystalline forms (2021-05-11),
2. 10562852 - Crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile (2020-02-18),
3. 9902694 - Crystalline forms (2018-02-27),
4. 8455497 - Inhibitors of aspartyl protease (2013-06-04),
5. 7834063 - Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors (2010-11-16),
6. 7723385 - Aniline derivatives as selective androgen receptor modulators (2010-05-25),
7. 7592368 - Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors (2009-09-22),
8. 7528127 - Short-acting benzodiazepines (2009-05-05),
9. 7514470 - Aniline derivatives as selective androgen receptor modulators (2009-04-07),
10. 7485635 - Short-acting benzodiazepines (2009-02-03),
11. 7473689 - Short-acting benzodiazepines (2009-01-06),
12. 7435730 - Short-acting benzodiazepines (2008-10-14),
13. 7195752 - Surfactant compounds and uses thereof (2007-03-27),
14. 7173134 - Selective RXR ligands (2007-02-06),
15. 7160880 - Short-acting benzodiazepines (2007-01-09),

Title: Inventor Istvan Kaldor: Pioneering Innovations in Durham

Introduction: Istvan Kaldor is a renowned inventor based in Durham, NC, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Istvan Kaldor holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Istvan Kaldor has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society. His commitment to pushing the boundaries of innovation is evident in the numerous successful projects he has been a part of.

Collaborations: Throughout his career, Istvan Kaldor has collaborated with top universities, tech companies, and research institutions to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the creation of revolutionary technologies that have the potential to shape the future.

Conclusion: Istvan Kaldor's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of inventors. His work continues to inspire the next generation of innovators and serves as a testament to the power of creativity and perseverance in driving progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…